Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - KeyCorp reduced their FY2018 earnings per share estimates for Acadia Healthcare in a note issued to investors on Monday. KeyCorp analyst J. Gurda now anticipates that the company will post earnings per share of $2.84 for the year, down from their prior estimate of $2.85. KeyCorp currently has a “Overweight” rating and a $51.00 target price on the stock. KeyCorp also issued estimates for Acadia Healthcare’s FY2019 earnings at $3.32 EPS.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The firm had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. During the same period last year, the firm earned $0.73 earnings per share. The company’s revenue for the quarter was down 5.4% compared to the same quarter last year.
ILLEGAL ACTIVITY NOTICE: “Equities Analysts Issue Forecasts for Acadia Healthcare Company, Inc.’s FY2018 Earnings (ACHC)” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://stocknewstimes.com/2017/08/03/equities-analysts-issue-forecasts-for-acadia-healthcare-company-inc-s-fy2018-earnings-achc.html.
Several other analysts have also recently issued reports on ACHC. Deutsche Bank AG initiated coverage on shares of Acadia Healthcare in a research report on Wednesday, April 5th. They set a “buy” rating and a $53.00 target price on the stock. Zacks Investment Research cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Thursday, April 6th. Cantor Fitzgerald restated a “hold” rating and set a $45.00 target price on shares of Acadia Healthcare in a research report on Wednesday, April 26th. Jefferies Group LLC restated a “buy” rating on shares of Acadia Healthcare in a research report on Friday, May 5th. Finally, Leerink Swann cut shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research report on Monday, May 15th. Five analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. Acadia Healthcare currently has an average rating of “Buy” and an average price target of $59.21.
Shares of Acadia Healthcare (ACHC) traded up 2.12% on Tuesday, hitting $52.57. The stock had a trading volume of 1,304,816 shares. The stock has a market cap of $4.62 billion, a PE ratio of 577.69 and a beta of 1.15. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $56.20. The company has a 50 day moving average price of $48.90 and a 200-day moving average price of $44.01.
In other Acadia Healthcare news, Director William Grieco sold 2,000 shares of the company’s stock in a transaction dated Friday, June 16th. The shares were sold at an average price of $45.42, for a total value of $90,840.00. Following the transaction, the director now directly owns 47,013 shares in the company, valued at approximately $2,135,330.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Reeve B. Waud sold 50,000 shares of the company’s stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $45.09, for a total transaction of $2,254,500.00. The disclosure for this sale can be found here. Insiders have sold a total of 2,119,585 shares of company stock worth $104,503,747 over the last quarter. 11.10% of the stock is currently owned by insiders.
A number of institutional investors have recently modified their holdings of the company. Emerald Mutual Fund Advisers Trust bought a new position in shares of Acadia Healthcare during the first quarter worth approximately $210,000. Paloma Partners Management Co bought a new position in shares of Acadia Healthcare during the first quarter worth approximately $217,000. M&T Bank Corp bought a new position in shares of Acadia Healthcare during the first quarter worth approximately $230,000. World Asset Management Inc bought a new position in shares of Acadia Healthcare during the second quarter worth approximately $242,000. Finally, Summit Securities Group LLC bought a new position in shares of Acadia Healthcare during the second quarter worth approximately $248,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
